RWA
CPRX icon

Redhawk Wealth Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Redhawk Wealth Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-67,778
Closed -$1.47M – 346
2025
Q2 		$1.47M Buy
67,778
+13,407
+25% +$316K 0.18% 111
2025
Q1 		$1.32M Sell
54,371
-6,638
-11% -$149K 0.18% 103
2024
Q4 		$1.27M Buy
+61,009
New +$1.31M 0.17% 105
2023
Q2 		– Sell
-29,874
Closed -$495K – 208
2023
Q1 		$495K Sell
29,874
-1,636
-5% -$27K 0.17% 109
2022
Q4 		$586K Buy
+31,510
New +$485K 0.23% 104

Other funds holding CPRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return